Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Global X Genomics & Biotechnology ETF - USD
GNOM performance and flow charts
Performance
Flows
Historic performance and flows
Data as of April 24, 2026| 1M | 3M | YTD | 1Y | 3Y | 5Y | |
|---|---|---|---|---|---|---|
| Perf. | +7.67% | -7.03% | +0.74% | +41.51% | -6.56% | -50.60% |
| Flows | -$829K | +$1M | -$602K | -$14M | -$120M | +$1M |
Characteristics
The Global X Genomics & Biotechnology ETF - USD is built to track the Solactive Genomics Index - USD. This ETF provides physical exposure - by owning its shares you earn the return of the securities composing the index (as the ETF holds them directly). This share class generates a stream of income by distributing dividends.
| Management strategy | Passive |
| Strategy | Long Only |
| Provider | Global X |
| N° of holdings | 47 |
| Replication method | Direct (Physical) |
| Asset class | Equity |
| Dividend policy | Distributing |
Trailing 12m distribution yield | Join for free |
| Inception date | April 5, 2019 |
| ESG | No |
More data and info about GNOM on Trackinsight
Exposure
Data as of March 31, 2026Diversification
Total weight of top 15 holdings out of 47
Top 15 Holdings
Sectors
Countries
Similar ETFs
Trading data
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Volatility | +28.47% | +27.16% | +28.79% | +33.22% |
Max drawdown | -16.08% | -18.16% | -46.50% | -72.17% |
Max drawdown duration | 88d | 92d | 1075d | 1758d |
Time to recover | N/A | N/A | N/A | N/A |
Replication quality
Data as of March 31, 2026Create an account to view replication metrics
1 year cumulative return difference | |
|---|---|
| Best | Join for free |
| Worst | Join for free |
| daily return difference | |
|---|---|
| Average | Join for free |
| Worst | Join for free |
What type of ETF is GNOM?
GNOM is a Passive ETF that provides exposure to Equity assets. It is managed by Global X.
What index does GNOM track?
GNOM tracks the Solactive Genomics Index - USD, aiming to replicate its performance through full replication.
What does GNOM invest in?
This ETF provides exposure to Equities. It is part of the segment: BioTech & Genomics.
What is the expense ratio of GNOM?
The total expense ratio (TER) of GNOM is 0.5%, representing the annual fee charged by the fund manager.
When was GNOM launched?
GNOM was launched on April 5, 2019, marking its entry into the ETF market.
Who is the issuer of GNOM?
GNOM is issued by Global X.
What is the AUM of GNOM?
As of April 24, 2026, GNOM manages $51.60 M, reflecting the total assets held in the fund.
How has GNOM performed recently?
As of April 24, 2026, GNOM delivered a return of 7.67% over the past month (1M performance), -7.03% over the past three months (3M), and 0.74% year-to-date (YTD).
What are the recent fund flows for GNOM?
As of April 24, 2026, GNOM has seen net flows of -$829K in the past month (1M flow) and -$602K year-to-date (YTD).
Does GNOM pay dividends?
As of April 24, 2026, GNOM has a trailing 12-month distribution yield of 1.36%.
How many holdings are in GNOM
As of March 31, 2026, GNOM holds 47 securities in its portfolio. This level of diversification can influence the fund’s risk profile and exposure to individual assets.
How diversified is GNOM?
As of March 31, 2026, GNOM holds 47 securities, with 66.21% of its assets concentrated in its top 15 holdings.
What are the top holdings of GNOM?
As of March 31, 2026, GNOM holds a portfolio of 47 underlyings, with its largest positions including MODERNA INC, ARROWHEAD PHARMACEUTICALS INC and US74006W2070. These top holdings play a significant role in shaping the fund’s performance and exposure.
What countries or regions does GNOM invest in?
As of March 31, 2026, GNOM has its largest geographic exposures in USA.
What sectors or themes does GNOM focus on?
As of March 31, 2026, GNOM is primarily exposed to Health Care.
Advantages of ETFs over Mutual Funds1/6
Lower Costs
In this guide, we'll explore the advantages of ETFs over mutual funds, giving you valuable insights into why ETFs have gained significant popularity among investors like yourself.
Leveraged ETFs: Unlocking the Potential for Amplified Returns1/6
Understanding Leveraged ETFs
Explore leveraged ETFs: potential for amplified returns & risks. 5 ETFs to consider across equities, commodities & fixed income.
What is a Leveraged ETF?1/6
Introducing Leveraged and Inverse ETFs
In this guide, we'll dive into the world of leveraged ETFs, exploring their definition, mechanics, potential risks, and rewards.
Recent educational content
Asset TV
The ETF Show - Investors Can Fight Healthcare Inflation with Newly Launched ETFs
Adam Schenck, Principal and Managing Director of Fund Services at Milliman joined The ETF Show to discuss Milliman's first ETFs designed to hedge against rising healthcare inflation.
ETF Trends
ETF Industry KPIs April 20, 2026
The ETF Industry saw 14 New Launches, 1 Ticker Change and 16 closures last week.
Asset TV
The ETF Show - Investors Run to Cash Alternatives as Markets Remain Volatile
Jason England, Portfolio Manager and Fixed Income Strategist from Simplify joined The ETF Show to discuss investor allocations to fixed income as markets continue on their rollercoaster ride.
ETF Trends
ETF Industry KPIs March 30, 2026
The ETF Industry saw 33 New Launches, 1 Ticker Change and 9 closures last week.
Browse all educational columns
Expert-Built ETF Portfolios, All in One Place
Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.
